OOIR: Observatory of International Research

Papers

(The median citation count of Prostate International is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Comparison of three questionnaire forms used in the diagnosis of lower urinary tract symptoms: A prospective study	42
Oncological outcomes after radical prostatectomy of localized prostate cancer: stratified by magnetic resonance imaging and risk classification	31
Screening and validation of novel serum panel of microRNA in stratification of prostate cancer	20
Does androgenic alopecia aggravate the risk of prostate cancer? Evidence from Mendelian randomization	19
Prognosis after radical prostatectomy in men older than 75 years: long-term results from a single tertiary center	16
Propensity score matched analysis of functional outcome in five thousand cases of robot-assisted radical prostatectomy versus high-intensity focused ultrasound	16
Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center	14
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer	13
Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study	13
Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy	12
Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer	12
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer	12
The addition of peri-operative gentamicin with ciprofloxacin reduces infection and sepsis rates post transrectal prostate biopsy	12
The impact of conventional smoking versus electronic cigarette on the expression of VEGF, PEMPA1, and PTEN in rat prostate	11
Utility of transperineal template-guided mapping prostate biopsy in biopsy-naïve men with PI-RADS 1-2 on multiparametric magnetic resonance imaging	10
Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship	10
Does the type of the previous biopsy affect the fusion prostate biopsy results?	10
The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey	9
Association between predictors of progression of benign prostatic hyperplasia and moderate-to-severe prostatitis-like symptoms: A propensity score–matched analysis	9
Preoperative prostatic artery embolization before transurethral resection of the prostate for prostate glands larger than 80 mL: the first randomized controlled trial	8
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study	8
Open simple prostatectomy and robotic simple prostatectomy for large benign prostatic hyperplasia: Comparison of safety and efficacy	8
Risks and side effects in the medical management of benign prostatic hyperplasia	8
Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy	8
Changes in diagnosis rate and treatment trends of benign prostatic hyperplasia in Korea: A nationwide population-based cohort study	8

Evaluation of the efficiency of transurethral enucleation with bipolar energy according to prostate volume for patients with benign prostate hyperplasia	8
Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomy	8
The feasibility of distance to the tumor of biopsy cores to estimate the extracapsular extension	7
Molecular genetic testing does not improve the detection of fluoroquinolone resistance before transrectal prostate biopsy	7
The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naïve men according to PSA levels: A prop	7
Non-infectious complications following transrectal prostate needle biopsy – Outcomes from over 8000 procedures	7
Effects of bladder neck sparing on continence outcomes of robotic-assisted radical prostatectomy: a systemic review and metaanalysis	7
Clinical experience with active surveillance protocol using regular magnetic resonance imaging instead of regular repeat biopsy for monitoring: A study at a high-volume center in Korea	7
Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and c	7
The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer	7
Urine spermine and multiparametric magnetic resonance imaging for prediction of prostate cancer in Japanese men	6
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer	6
Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer	6
Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer	6
Predictors of readmission and impact of same-day discharge in holmium laser enucleation of the prostate	6
Comparisons of three scoring systems based on biparametric magnetic resonance imaging for prediction of clinically significant prostate cancer	6
Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates	6
Second primary cancer risk and survival in prostate cancer patients: A nationwide analysis	6
Detection of anterior prostate cancer using a magnetic resonance imaging-transrectal ultrasound fusion biopsy in cases with initial biopsy and history of systematic biopsies	6
Time to castrate the cost? the rising expense of chemical castration for the management of prostate cancer	6
Concurrent antiandrogen therapy in the salvage radiotherapy setting for recurrent prostate cancer: a literature review	6
Robotic-assisted simple prostatectomy versus holmium laser enucleation of the prostate for large benign prostatic hyperplasia: A single-center preliminary study in Korea	5
Assessing the influence of prostate tissue traits on Gallium-68 prostate-specific membrane-antigen positron-emission tomography/computed tomography: predictive factors for image positivity and locoreg	5
Efficacy of tamsulosin 0.4 mg for the treatment in male with the international Prostate Symptom Score ≥ 20 compared with tamsulosin 0.2 mg	5
Association between preradiation therapy prostate-specific antigen levels and radiation therapy failure after prostatectomy: a propensity score matched analysis	5
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia	5
Twelve-year outcomes of prostate cancer after radical prostatectomy for T3 and/or positive margins managed with surveillance or salvage radiation therapy, based on risk groups	5
A comparison of surgical outcomes between outpatient and inpatient robot-assisted radical prostatectomy: A systematic review and meta-analysis	5
Detection of recurrence sites using 18F-fluorocholine PET/CT in prostate cancer patients with PSA failure	5
A novel anterior approach that involves Retzius space development between the umbilical ligaments is associated with a lower incidence of postoperative inguinal hernia in robotic radical prostatectomy	5
Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign	5
The effect of systemic hypertension on prostatic artery resistive indices in patients with benign prostate enlargement	5
Association between preoperative prostate-specific antigen levels and mortality in high- and intermediate-grade prostate cancer patients who received radical prostatectomy: Findings from the SEER data	5
Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: A multi-institutional study	5
Safety and efficacy of tamsulosin 0.4 mg as an initial dose in 1,219 Korean patients with moderate to severe lower urinary tract symptoms: data from a phase IV study	5
Pain relieving effect of music on patients during transrectal ultrasonography: A pilot study	5
Safety and efficacy of extracorporeal shockwave therapy on chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled study	5
Changing trends in robot-assisted radical prostatectomy: Inverse stage migration—A retrospective analysis	4
Temporal changes of PIRADS scoring by radiologists and correlation to radical prostatectomy pathological outcomes	4
Use versus nonuse of antimicrobial prophylaxis prior to transperineal prostate biopsy: a propensity score-matched analysis	4
Sex hormones, blood metabolites and proteins mediating the causal associations between gut microbiota and prostatic diseases: evidences from Mendelian randomization study	4
Challenges in next generation sequencing of homology recombination repair genomic variants in prostate cancer: A nationwide survey and calibration project in China	4
Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer	4
Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study	4
Comparison of oncological outcomes between extended and no pelvic lymph node dissection in patients with high- or very high-risk prostate cancer: a multi-institutional study	4
Hematospermia does not increase the risk of prostate cancer detection in prostate biopsy	4
Dr. Answer AI for prostate cancer: Intention to use, expected effects, performance, and concerns of urologists	4
Corrigendum to “Screening and validation of novel serum panel of microRNA in stratification of prostate cancer” [Prostate Int 11 (2023) 150–158]	4
The prognostic value of elimination rate constant K score of prostate-specific antigen in metastatic castration-resistant prostate cancer patients treated with docetaxel	4
Incidence and risk factors for dermatologic adverse events following apalutamide use: a real-world data analysis in the Korean population	4

A systematic review of outcomes after thermal and nonthermal partial prostate ablation	3
Changes of resistance indices after medication in benign prostatic hyperplasia: a prospective study	3
Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study	3
The relationship between depression, anxiety and lower urinary tract symptoms in men	3
Width of spared neurovascular bundle after robot-assisted laparoscopic prostatectomy in patients with prostate cancer: is it a reliable factor for predicting postoperative sexual outcome?	3
Rebiopsy rate after transperineal or transrectal prostate biopsy	3
Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer	3
Minimal invasive management of bladder neck contracture using Allium round posterior stent: the long-term results	3
Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description	3
Comparison of intrarectal heated lidocaine gel and periprostatic nerve block for pain control in transrectal ultrasound-guided prostate biopsy: A randomized controlled non-inferiority trial	3
Oral chemotherapeutic agents in metastatic hormone-sensitive prostate cancer: A network meta-analysis of randomized controlled trials	3